ID29089A - Sediaan farmasi moksifloksasin - Google Patents

Sediaan farmasi moksifloksasin

Info

Publication number
ID29089A
ID29089A IDW00200101040A ID20011040A ID29089A ID 29089 A ID29089 A ID 29089A ID W00200101040 A IDW00200101040 A ID W00200101040A ID 20011040 A ID20011040 A ID 20011040A ID 29089 A ID29089 A ID 29089A
Authority
ID
Indonesia
Prior art keywords
moksifloxasin
pharmaceutical properties
pharmaceutical
properties
moksifloxasin pharmaceutical
Prior art date
Application number
IDW00200101040A
Other languages
English (en)
Indonesian (id)
Inventor
Patrick Bosche
Hans Friedrich Mahler
Claus Weisemann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID29089(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ID29089A publication Critical patent/ID29089A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW00200101040A 1998-11-10 1999-10-29 Sediaan farmasi moksifloksasin ID29089A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19855758 1998-11-10

Publications (1)

Publication Number Publication Date
ID29089A true ID29089A (id) 2001-07-26

Family

ID=7889824

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101040A ID29089A (id) 1998-11-10 1999-10-29 Sediaan farmasi moksifloksasin

Country Status (41)

Country Link
US (1) US6610327B1 (es)
EP (1) EP1128831B1 (es)
JP (1) JP4809978B2 (es)
KR (1) KR100650489B1 (es)
CN (1) CN1149993C (es)
AR (1) AR021074A1 (es)
AT (1) ATE279193T1 (es)
AU (1) AU745282B2 (es)
BG (1) BG64974B1 (es)
BR (2) BR9915208A (es)
CA (1) CA2349161C (es)
CO (1) CO5070571A1 (es)
CU (1) CU23260B7 (es)
CZ (1) CZ292069B6 (es)
DE (1) DE59910858D1 (es)
DK (1) DK1128831T3 (es)
EE (1) EE04418B1 (es)
ES (1) ES2229786T3 (es)
HK (1) HK1042245B (es)
HN (1) HN1999000183A (es)
HR (1) HRP20010332B1 (es)
HU (1) HU229065B1 (es)
ID (1) ID29089A (es)
IL (2) IL142642A0 (es)
MA (1) MA26757A1 (es)
MY (1) MY121114A (es)
NO (1) NO319342B1 (es)
NZ (1) NZ511554A (es)
PE (1) PE20001304A1 (es)
PL (1) PL194020B1 (es)
PT (1) PT1128831E (es)
RU (1) RU2230555C9 (es)
SI (1) SI1128831T1 (es)
SK (1) SK283936B6 (es)
SV (1) SV1999000194A (es)
TR (1) TR200101310T2 (es)
TW (1) TW580388B (es)
UA (1) UA72483C2 (es)
UY (1) UY25792A1 (es)
WO (1) WO2000027398A1 (es)
ZA (1) ZA200103141B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
EP1663226A1 (en) * 2003-09-03 2006-06-07 Ranbaxy Laboratories Limited Pharmaceutical compositions of moxifloxacin and processes for their preparation
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
CN1330306C (zh) * 2004-08-11 2007-08-08 深圳市天一时科技开发有限公司 莫西沙星明胶胶囊剂及其制备方法
WO2007033522A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
CN100363001C (zh) * 2005-09-21 2008-01-23 深圳市天一时科技开发有限公司 一种莫西沙星胶囊剂及其制备方法
US8314122B2 (en) * 2008-10-09 2012-11-20 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Using of organic solvents in wet granulation of moxifloxacin
EP2735307A1 (de) 2008-12-08 2014-05-28 Ratiopharm GmbH Kompaktiertes Moxifloxacin
TR200907227A2 (tr) * 2009-09-18 2011-04-21 Bi̇lgi̇ç Mahmut Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) * 2009-11-16 2013-09-11 江苏亚邦强生药业有限公司 莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) * 2010-01-12 2011-07-21 Msn Laboratories Limited Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) * 2010-06-11 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) * 2011-01-12 2011-11-23 北京润德康医药技术有限公司 一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
MX2011004759A (es) 2011-05-04 2012-11-21 Senosiain S A De C V Lab Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) * 2011-10-14 2012-11-20 Закрытое акционерное общество "Брынцалов-А" Фармацевтический препарат моксифлоксацина
US9675582B2 (en) 2011-10-25 2017-06-13 U.S. Phytotherapy, Inc. Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
WO2013063271A1 (en) * 2011-10-25 2013-05-02 U.S. Phytotherapy, Inc. Artemisinin and berberine compositions and methods of making
EP2770985A4 (en) 2011-10-25 2015-01-21 U S Phytotherapy Inc ARTEMISININE AND BERBERINE COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
US9358261B2 (en) 2011-10-25 2016-06-07 U.S. Phytotherapy, Inc. Additional artemisinin and berberine compositions and methods of making
WO2013081044A1 (ja) * 2011-11-30 2013-06-06 富山化学工業株式会社 １－シクロプロピル－８－（ジフルオロメトキシ）－７－［（１ｒ）－１－メチル－２，３－ジヒドロ－１ｈ－イソインドール－５－イル］－４－オキソ－１，４－ジヒドロキノリン－３－カルボン酸のメタンスルホン酸塩水和物含有錠剤
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) * 2012-02-21 2012-07-04 天津市汉康医药生物技术有限公司 一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) * 2012-04-11 2013-06-05 南京优科生物医药有限公司 一种莫西沙星片剂及其制备方法
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) * 2012-10-19 2016-04-20 深圳信立泰药业股份有限公司 一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) * 2013-12-20 2015-06-25 씨제이헬스케어 주식회사 목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) * 2014-05-22 2015-08-10 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd ６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
TW209865B (es) * 1992-01-10 1993-07-21 Bayer Ag
DE19546249A1 (de) 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino

Also Published As

Publication number Publication date
BRPI9915208B8 (pt) 2021-07-06
CZ292069B6 (cs) 2003-07-16
CU23260B7 (es) 2008-01-24
ZA200103141B (en) 2002-05-07
JP2002529415A (ja) 2002-09-10
JP4809978B2 (ja) 2011-11-09
EE04418B1 (et) 2005-02-15
KR20010089424A (ko) 2001-10-06
RU2230555C2 (ru) 2004-06-20
MY121114A (en) 2005-12-30
HU229065B1 (en) 2013-07-29
ES2229786T3 (es) 2005-04-16
AU1267400A (en) 2000-05-29
CA2349161A1 (en) 2000-05-18
NO319342B1 (no) 2005-07-18
BRPI9915208B1 (pt) 2011-11-01
DE59910858D1 (de) 2004-11-18
BRPI9915208A (pt) 2001-07-31
UA72483C2 (en) 2005-03-15
SK283936B6 (sk) 2004-05-04
IL142642A (en) 2006-10-05
KR100650489B1 (ko) 2006-11-28
NO20012248L (no) 2001-06-06
HRP20010332B1 (en) 2011-01-31
UY25792A1 (es) 2001-08-27
MA26757A1 (fr) 2004-12-20
HUP0104762A2 (hu) 2002-05-29
SK6102001A3 (en) 2001-12-03
NZ511554A (en) 2003-07-25
HN1999000183A (es) 1999-11-01
AU745282B2 (en) 2002-03-21
WO2000027398A1 (de) 2000-05-18
DK1128831T3 (da) 2005-01-17
NO20012248D0 (no) 2001-05-07
CO5070571A1 (es) 2001-08-28
EP1128831A1 (de) 2001-09-05
HRP20010332A2 (en) 2002-06-30
TW580388B (en) 2004-03-21
BG64974B1 (bg) 2006-11-30
BR9915208A (pt) 2001-07-31
TR200101310T2 (tr) 2001-10-22
SI1128831T1 (en) 2005-04-30
HK1042245A1 (en) 2002-08-09
PL194020B1 (pl) 2007-04-30
EE200100259A (et) 2002-12-16
PT1128831E (pt) 2005-01-31
US6610327B1 (en) 2003-08-26
ATE279193T1 (de) 2004-10-15
PL348112A1 (en) 2002-05-06
CZ20011652A3 (cs) 2001-08-15
CN1325306A (zh) 2001-12-05
PE20001304A1 (es) 2000-12-30
CN1149993C (zh) 2004-05-19
CA2349161C (en) 2008-01-29
AR021074A1 (es) 2002-06-12
SV1999000194A (es) 2000-10-16
HUP0104762A3 (en) 2002-10-28
HK1042245B (zh) 2005-03-11
BG105459A (en) 2001-12-29
EP1128831B1 (de) 2004-10-13
IL142642A0 (en) 2002-03-10
RU2230555C9 (ru) 2006-02-27

Similar Documents

Publication Publication Date Title
ID29089A (id) Sediaan farmasi moksifloksasin
ID27415A (id) Komposisi farmaseutik
IS5046A (is) Lyfjasamsetningar
NO20005913D0 (no) Legemiddelsammensetning
NO20015175D0 (no) Farmasöytisk sammensetning
DE69918109D1 (de) Haarwaschmittel
ID29262A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
NO992692D0 (no) Nefadozon doseringsform
ID27201A (id) Komposisi farmasi
NO20022606L (no) Farmasöytiske kombinasjoner
ID27150A (id) Sediaan levotiroksin bahan farmasi
DE69928344D1 (de) Pharmazeutisches Implantat
DE69937642D1 (de) Trimaranstruktur
ID30032A (id) Formulasi farmasi
FI4488U1 (fi) Farmaseuttinen koostumus
IS6163A (is) Lyfjakomplex
ID26215A (id) Komposisi farmasi
FR2782671B3 (fr) Livre
DE29812729U1 (de) Siebrechen
SE9801216D0 (sv) Pharmaceuticals
DE29821063U1 (de) Kanüle
DE29803118U1 (de) Kanüle
SE9800052D0 (sv) Pharmaceutical compositions
SE9800330D0 (sv) Pharmaceutical compositions